Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Ronald Evans

Tracked across 1 events · 6 articles · First seen Jun 09, 2026 · Last active Jun 16, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Tech
Impact: Ronald Evans, a professor at the Salk Institute for Biological Studies and co-author of the study, emphasized the novel approach of using vitamin D analogs to overcome therapeutic resistance in pancreatic cancer. His expertise and commentary are central to the study's interpretation.
Jun 09, 2026 · 6 articles
60 Ronald Evans commented on approachVitamin D Boosts...
ERGEN INTELLIGENCE
Track Ronald Evans live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.